|
Experiemental period (n = 17) |
SMT (n = 10) |
SHAM (n = 7) | Significance between groups |
|---|---|---|---|
| D-2 | 50.50 (6.25) | 42.85 (7.46) | 0.43 |
| D1PRE treatment | 28.70 (6.24) | 29.28 (7.46) | 0.95 |
| D1POST treatment | 15.30 (6.24)b | 25.71 (7.46) | 0.28 |
| D5 | 36.60 (6.24)a | 40.57 (7.46) | 0.68 |
| D7PRE treatment | 24.40 (6.24) | 18.85 (7.46) | 0.57 |
| D7POST treatment | 12.60 (6.24)b | 18.14 (7.46) | 0.57 |
| All experimental period | 28.01 (2.55) | 29.23 (3.04) | 0.75 |
| Significance within groups | 0.001* | 0.09 |